Caitlin Wiafe-Kwakye

Dr. Caitlin Wiafe-Kwakye


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in Molecular Microbiology
Verified
Journal Article
Closed access
BSBrady L. Spencer
Brady L. Spencer
AJAlyx M. Job
Alyx M. Job
CRClare M. Robertson
Clare M. Robertson
ZHZainab A. Hameed
Zainab A. Hameed
CSCamille Serchejian
Camille Serchejian
KDKelly Doran
Kelly Doran

25 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBrady L. Spencer
Brady L. Spencer
AJAlyx M. Job
Alyx M. Job
CRClare M. Robertson
Clare M. Robertson
ZHZainab A. Hameed
Zainab A. Hameed
CSCamille Serchejian
Camille Serchejian
KDKelly Doran
Kelly Doran
SUMMARY: Type VIIb secretion systems (T7SSb) in Gram-positive bacteria facilitate physiology, interbacterial competition, and/or virulence via EssC ATPase-driven secretion of small ɑ-helical proteins and toxins. Recently, we characterized T7SSb in group B Streptococcus (GBS), a leading cause of infection in newborns and immunocompromised adults. GBS T7SS comprises four subtypes based on variation in the C-terminus of EssC and the repertoire of downstream effectors; however, the intra-species diversity of GBS T7SS and impact on GBS-host interactions remains unknown. Bioinformatic analysis indicates that GBS T7SS loci encode subtype-specific putative effectors, which have low inter-species and inter-subtype homology but contain similar domains/motifs and therefore may serve similar functions. We further identify orphaned GBS WXG100 proteins. Functionally, we show that GBS T7SS subtype I and III strains secrete EsxA in vitro and that in subtype I strain CJB111, esxA1 appears to be differentially transcribed from the T7SS operon. Further, we observe subtype-specific effects of GBS T7SS on host colonization, as subtype I but not subtype III T7SS promotes GBS vaginal persistence. Finally, we observe that T7SS subtypes I and II are the predominant subtypes in clinical GBS isolates. This study highlights the potential impact of T7SS heterogeneity on host-GBS interactions.

23 July 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
CWCaitlin Wiafe-Kwakye
Caitlin Wiafe-Kwakye
AFAndrew Fournier
Andrew Fournier
HMHannah Maurais
Hannah Maurais
KSKatie Southworth
Katie Southworth
SMSally Molloy
Sally Molloy
MNMelody Neely
Melody Neely
Prophages, viral genomes integrated into bacterial genomes, are known to enhance bacterial colonization, adaptation, and ecological fitness, providing a better chance for pathogenic bacteria to disseminate and cause infection. Streptococcus agalactiae (Group B Streptococcus or GBS) is a common bacterium found colonizing the genitourinary tract of humans. However, GBS-colonized pregnant women are at risk of passing the organism to the neonate, where it can cause severe infections. GBS typically encode one or more prophages in their genomes, yet their role in pathogen fitness and virulence has not yet been described. Sequencing and bioinformatic analysis of the genomic content of GBS human isolates identified 42 complete prophages present in their genomes. Comparative genomic analyses of the prophage sequences revealed that the prophages could be classified into five distinct clusters based on their genomic content, indicating significant diversity in their genetic makeup. Prophage diversity was also identified across GBS capsule serotypes, sequence types (STs), and clonal clusters (CCs). Comprehensive genomic annotation revealed that all GBS strains encode paratox, a protein that prevents the uptake of DNA in Streptococcus, either on the chromosome, on the prophage, or both, and each prophage genome has at least one toxin-antitoxin system.

20 August 2026 in Journal of Bacteriology
Verified
Journal Article
Open access
CWCaitlin Wiafe-Kwakye
Caitlin Wiafe-Kwakye
AGAbigail E. Glenn
Abigail E. Glenn
BSBrady L. Spencer
Brady L. Spencer
The type VII secretion system (T7SS) is an ATPase-powered molecular machine encoded by Actinomycetota (T7SSa) and Bacillota (T7SSb) that exports small alpha-helical effectors with functions in interbacterial competition, host colonization, and virulence. While T7SSb has been well characterized in Staphylococcus aureus and Bacillus subtilis , its presence and function within the order Lactobacillales have only been thoroughly investigated within the past decade. Experimental evidence for T7SSb function has now been established in select Streptococcus and Enterococcus species. Here, we review the current understanding of T7SSb in these genera, covering core machinery and secreted substrates, including LXG toxins and WXG100 proteins. We discuss the roles of T7SSb during interbacterial antagonism and host-pathogen interactions, including contributions to cytotoxicity and virulence, as well as mucosal colonization and persistence. We further review known regulators of the T7SSb and evaluate the ecological significance of T7SSb-mediated competition for microbial community stability. Finally, we highlight outstanding questions in the field, including mechanisms of effector delivery, structural determination of the apparatus, impact of effectors on host immunity, and potential therapeutic targeting of T7SSb components.

8 June 2020 in Proceedings
Verified
Conference Paper
Open access
PDF file
MNMelody Neely
Melody Neely
CWCaitlin Wiafe-Kwakye
Caitlin Wiafe-Kwakye
SMSally Molloy
Sally Molloy
Bacteriophages (phage) are viruses that specifically infect bacteria and contribute to their evolution. Nearly all bacterial pathogens contain integrated phage, or prophage, within their genome, and many phage genes are associated with bacterial virulence and/or bacterial fitness. Prophages that are associated with the virulence of human pathogens include those found in Vibrio cholerae, Salmonella sp., Staphylococcus aureus, and Streptococcus pyogenes. Streptococcus agalactiae (Group B streptococcus or GBS) also contain prophages and, in many cases, multiple prophages in a single strain. GBS is an opportunistic pathogen that is found associated with the mucus membranes of the genitourinary tract in about 25% of the adult population. However, if GBS colonizes an immunocompromised individual (such as a neonate or pregnant mother), it can invade and survive in the bloodstream, resulting in serious morbidity and mortality. Unfortunately, treatment of neonates with antibiotics results in disruption of their normal gut microflora and has major effects on the development of their immune system. In order to address the threat of GBS to newborns, we need to fully understand the mechanisms by which this pathogen causes disease. We hypothesize that phage integration into the S. agalactiae genome may enhance pathogenicity and play a role in neonatal-associated infection. Through analysis of the genome sequences of seven S. agalactiae strains, we detected intact phage sequences in three out of the seven strains, which are A909, CNCTC 10/84, and 2603V/R. We have successfully cured the prophage, Callidus, from the CNCTC10/84 genome by overexpression of the excise gene. Comparative analyses between the WT lysogen and the cured strain show differences in chain length, cell morphology and virulence using a well-established zebrafish infectious disease model. Understanding GBS virulence mechanisms is key to developing novel, effective treatments and vaccines for GBS.